Orion Portfolio Solutions LLC Acquires 5,888 Shares of Colgate-Palmolive (NYSE:CL)

Orion Portfolio Solutions LLC increased its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 13.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,526 shares of the company’s stock after acquiring an additional 5,888 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Colgate-Palmolive were worth $4,062,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of CL. NBC Securities Inc. bought a new position in shares of Colgate-Palmolive in the 3rd quarter worth about $368,000. Flputnam Investment Management Co. increased its stake in Colgate-Palmolive by 9.9% during the 3rd quarter. Flputnam Investment Management Co. now owns 16,118 shares of the company’s stock valued at $1,146,000 after purchasing an additional 1,450 shares in the last quarter. Wealthspire Advisors LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at about $223,000. Cornerstone Wealth Management LLC increased its stake in Colgate-Palmolive by 12.4% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 6,998 shares of the company’s stock valued at $498,000 after purchasing an additional 772 shares in the last quarter. Finally, South Dakota Investment Council increased its stake in Colgate-Palmolive by 18.3% during the 3rd quarter. South Dakota Investment Council now owns 26,753 shares of the company’s stock valued at $1,902,000 after purchasing an additional 4,130 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the sale, the insider now owns 3,181 shares in the company, valued at $297,328.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. Company insiders own 0.37% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Citigroup raised their price objective on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 16th. Morgan Stanley lifted their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research note on Monday, January 29th. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a research note on Monday, January 29th. The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a research note on Friday, March 1st. They issued a “buy” rating and a $93.00 price target for the company. Finally, Argus lifted their price target on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research note on Wednesday, May 15th. Three research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.35.

Check Out Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $93.30 on Tuesday. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $95.59. The company has a market capitalization of $76.55 billion, a P/E ratio of 29.53, a P/E/G ratio of 3.44 and a beta of 0.40. The firm’s 50 day simple moving average is $90.48 and its two-hundred day simple moving average is $84.62.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the previous year, the firm earned $0.73 earnings per share. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. Research analysts expect that Colgate-Palmolive will post 3.53 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd were given a dividend of $0.50 per share. The ex-dividend date was Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.